GS vs NBIS: Which Is the Better Buy?

Side-by-side comparison of The Goldman Sachs Group, Inc. and Nebius Group N.V. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
The Goldman Sachs Group, Inc. Β· Financial Services
$923.29
+25.9% upside to fair value
Med Conviction Grade C High Quality
VS
Nebius Group N.V. Β· Technology
$217.99
+45.0% upside to fair value
Med Conviction Grade B
QuantHub Verdict
NBIS has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GS NBIS
Current Price $923.29 $217.99
Fair Value Estimate $1,162.79 $316.09
Upside to Fair Value +25.9% +45.0%
Market Cap $272.4B $52.3B
Forward P/E β€” β€”
EV / EBITDA 26.3x 56.8x
Price / Sales 2.3x 38.6x
Price / FCF β€” β€”
Revenue Growth YoY +22.9% +454.0%
Gross Margin 57.3% 58.6%
Operating Margin 24.8% -49.3%
Return on Equity 17.0% 0.9%
Dividend Yield 1.95% 0%
FCF Yield β€” β€”
Analyst Consensus Hold Strong Buy
Investment Thesis
GS β€” The Goldman Sachs Group, Inc.
Goldman Sachs is a global financial services firm operating four divisions: Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management, with 46,200 full-time employees and a market cap of $272.38 billion at a current price of $923.29. The business quality is high because of its leading franchise in advisory, underwriting, and trading, evidenced by a 17.0% ROE, a 57.3% …
NBIS β€” Nebius Group N.V.
Nebius Group N.V. is an Amsterdam-based AI infrastructure company, formerly Yandex N.V., that builds end-to-end GPU cloud clusters, cloud platforms and developer tools for demanding AI workloads, alongside Toloka AI data solutions, TripleTen education and Avride autonomous driving. The business is growing explosively, with revenue up 454.0% year over year in the most recent quarter, and it has de…
Accumulation Zones
Metric GS NBIS
Zone Low $872.09 $237.07
Zone High $988.37 $268.68
In Buy Zone? Yes Yes
← GS Research    NBIS Research β†’    All Research